Together Pharma Statistics
Total Valuation
Together Pharma has a market cap or net worth of ILS 58.30 million. The enterprise value is 118.31 million.
Market Cap | 58.30M |
Enterprise Value | 118.31M |
Important Dates
The last earnings date was Monday, March 31, 2025.
Earnings Date | Mar 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Together Pharma has 13.81 million shares outstanding. The number of shares has increased by 41.39% in one year.
Current Share Class | n/a |
Shares Outstanding | 13.81M |
Shares Change (YoY) | +41.39% |
Shares Change (QoQ) | +8.40% |
Owned by Insiders (%) | 68.79% |
Owned by Institutions (%) | n/a |
Float | 4.31M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.61 |
PB Ratio | 1.53 |
P/TBV Ratio | 6.77 |
P/FCF Ratio | 42.43 |
P/OCF Ratio | 20.46 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.71, with an EV/FCF ratio of 86.11.
EV / Earnings | -100.95 |
EV / Sales | 1.23 |
EV / EBITDA | 11.71 |
EV / EBIT | 36.16 |
EV / FCF | 86.11 |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 1.66.
Current Ratio | 1.07 |
Quick Ratio | 0.35 |
Debt / Equity | 1.66 |
Debt / EBITDA | 6.29 |
Debt / FCF | 46.26 |
Interest Coverage | 0.35 |
Financial Efficiency
Return on equity (ROE) is -9.09% and return on invested capital (ROIC) is 2.66%.
Return on Equity (ROE) | -9.09% |
Return on Assets (ROA) | 1.43% |
Return on Invested Capital (ROIC) | 2.66% |
Return on Capital Employed (ROCE) | 4.80% |
Revenue Per Employee | 482,678 |
Profits Per Employee | -5,889 |
Employee Count | 199 |
Asset Turnover | 0.67 |
Inventory Turnover | 1.41 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.35% in the last 52 weeks. The beta is 0.44, so Together Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.44 |
52-Week Price Change | -15.35% |
50-Day Moving Average | 445.14 |
200-Day Moving Average | 429.82 |
Relative Strength Index (RSI) | 47.93 |
Average Volume (20 Days) | 11,215 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Together Pharma had revenue of ILS 96.05 million and -1.17 million in losses. Loss per share was -0.09.
Revenue | 96.05M |
Gross Profit | 17.51M |
Operating Income | 3.27M |
Pretax Income | -2.21M |
Net Income | -1.17M |
EBITDA | 8.93M |
EBIT | 3.27M |
Loss Per Share | -0.09 |
Balance Sheet
The company has 8.44 million in cash and 63.57 million in debt, giving a net cash position of -55.12 million or -3.99 per share.
Cash & Cash Equivalents | 8.44M |
Total Debt | 63.57M |
Net Cash | -55.12M |
Net Cash Per Share | -3.99 |
Equity (Book Value) | 38.21M |
Book Value Per Share | 2.41 |
Working Capital | 5.68M |
Cash Flow
In the last 12 months, operating cash flow was 2.85 million and capital expenditures -1.48 million, giving a free cash flow of 1.37 million.
Operating Cash Flow | 2.85M |
Capital Expenditures | -1.48M |
Free Cash Flow | 1.37M |
FCF Per Share | 0.10 |
Margins
Gross margin is 18.23%, with operating and profit margins of 3.41% and -1.22%.
Gross Margin | 18.23% |
Operating Margin | 3.41% |
Pretax Margin | -2.30% |
Profit Margin | -1.22% |
EBITDA Margin | 9.30% |
EBIT Margin | 3.41% |
FCF Margin | 1.43% |
Dividends & Yields
Together Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -41.39% |
Shareholder Yield | -41.39% |
Earnings Yield | -2.01% |
FCF Yield | 2.36% |
Stock Splits
The last stock split was on August 13, 2023. It was a reverse split with a ratio of 0.1.
Last Split Date | Aug 13, 2023 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Together Pharma has an Altman Z-Score of -0.94. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.94 |
Piotroski F-Score | n/a |